NCT01367054View on ClinicalTrials.gov

Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg

NAUnknownINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

December 31, 2011

Conditions
Nutritional and Metabolic Diseases
Interventions
DRUG

Metformin

500 mg tablet

DRUG

Glifage

500 mg tablet

Trial Locations (1)

85903-590

Biocinese, Toledo

Sponsors

Lead Sponsor

Biocinese
All Listed Sponsors
lead

Biocinese

INDUSTRY